Cargando…
Transthyretin amyloid cardiomyopathy disease burden quantified using (99m)Tc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours
BACKGROUND: Various parameters derived from technetium-99m pyrophosphate ((99m)Tc-PYP) single-photon emission computed tomography (SPECT) correlate with the severity of transthyretin amyloid cardiomyopathy (ATTR-CM). However, the optimal metrics and image acquisition timing required to quantify the...
Autores principales: | Watanabe, Satoru, Nakajima, Kenichi, Toshima, Fumihito, Wakabayashi, Hiroshi, Yoshida, Shohei, Yoneyama, Hiroto, Komatsu, Junji, Konishi, Takahiro, Kinuya, Seigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682282/ https://www.ncbi.nlm.nih.gov/pubmed/37605060 http://dx.doi.org/10.1007/s12350-023-03353-w |
Ejemplares similares
-
Volumetric evaluation of (99m)Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters
por: Watanabe, Satoru, et al.
Publicado: (2021) -
Usefulness of quantitative (99m)Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis
por: Ogasawara, Kouji, et al.
Publicado: (2022) -
Assessment of cardiac amyloidosis with (99m)Tc-pyrophosphate (PYP) quantitative SPECT
por: Ren, Chao, et al.
Publicado: (2021) -
Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019) -
CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)